Rempex Pharmaceuticals
About:
Rempex Pharmaceuticals engages in the discovery and development of antibacterial drugs for antibiotic resistance.
Website: http://www.rempexpharma.com
Top Investors: OrbiMed, Adams Street Partners, SV Health Investors, Vivo Capital, Frazier Healthcare Partners
Description:
Rempex Pharmaceuticals, Inc. is a San Diego-based pharmaceutical company focused on the discovery and development of new antibacterial drugs to meet the growing clinical need created by multi-drug resistant bacterial pathogens. The company’s internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacteria responsible for antibiotic resistance.
$67.5M
$1M to $10M
San Diego, California, United States
2011-01-01
info(AT)rempexpharma.com
Daniel D. Burgess, Jeffery Loutit, Michael Dudley
1001-5000
2011-11-09
Private
© 2025 bioDAO.ai